« Physician Payment Sunshine Act: CMS Launches National Physician Payment Transparency Program Website, Forms and Templates | Main | HHS OIG Report: FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies (REMS) Improve Drug Safety »

February 22, 2013

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb8834017ee89c9231970d

Listed below are links to weblogs that reference HHS OIG: Listing of Pharmaceutical and Device Corporate Integrity Agreements:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Sponsors

Enter your email address:

Delivered by FeedBurner

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30